ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
32 hedge funds and large institutions have $35.7M invested in Anthera Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
6
Increased
10
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
MCM
Moore Capital Management
New York
|
-$926K |
| 2 |
VM
VHCP Management
New York
|
-$666K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$614K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$463K |
| 5 |
B
Bailard
Foster City,
California
|
-$265K |
